3Mattern J, Koomagi R, Volm M. Biological characterization of subgroups of squamous cell lung carcinomas [ J]. Clin Cancer Res, 1999,5 ( 6 ) : 1459.
4Ghosh S, Panaeeione R. Anti-adhesion molecule therapy for inflammatory bowel disease[ J]. Therap Adv Gastroenterol, 2010,3(4) :239.
5Deves R,Boyd CA. Surface antigen CD98 (4F2):not a single membrane protein, but a family of proteins with mul- tiple functions [ J ]. J Membr Biol,2000,173 (3) : 165.
6Fenczik CA,Sethi T, Ramos JW, et al. Complementation of dominant suppression implicates CD98 in integrin activa- tion[ J]. Nature, 1997,390( 6655 ) :81.
7Rintoul RG, Buttery RC, Mackinnon AC, et al. Cross-link- ing CD98 promotes integrin-like signaling and anchorage- independent growth [ J ]. Mol Biol Cell,2002,13 ( 8 ) :2841.
7Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol, 2005,21:408-413.
8Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease : controversies, consensus, and implications. Gut, 2006, 55 : 749-753.
9Kornbluth A, Sachar D. Ulcerative colitis practice guidelines in adults (update). Am J Gastroenterol, 2004,99 : 1371-1385.
10Hanauer SB, Sandbom W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001,96: 635-643.
1Kllisch G,Kalali BN,Voelcker V,et al.Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes[J].Immunology,2005;114(4):531-541.
2Zeng H,Wu H,Sloane V,et al.Flagellin/TLR5 responses in epithelia reveal intertwined activation of inflammatory and apoptotic pathways[J].Am J Physiol Gastrointest Liver Physiol,2006;290(1):G96-G108.
3Van Maele L,Carnoy C,Cayet D,et al.TLR5 signaling stimulates the innate production of IL-17 and IL-22 byCD3(neg)CD127+ immune cells in spleenand mucosa[J].J Immunol,2010,185(2):1177-1185.
4S.C.Truelove,L.J.WittsCortisone in Ulcerative Colitis[J].Br Med J,1955,2(4947):1041-1048.
5Li GX,Li N.Toll like receptors on intestinal barrier is protection or damage[J].Chin J Gastrointest Surg,2009,12(5):540-541.
6Sen R,Baltimore D.Multiple nuclear factors interact with the immunoglobulin enhancer sequences[J].J Cell,1986,46(5):705-716.
7Hoesel B,Schmid JA.The complexity of NF-κB signaling in inflammation and cancer[J].Mol Cancer,2013,12:86.
8Kobayashi T,Okamoto S,Hisamatsu T,et al.IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease[J].Gut,2008,57 (12):1682-1689.
9Fujino S,Andoh A,Bamba S,et al.Increased expression of interleukin 17 in inflammatory bowel disease[J].Gut,2003,52(1):65-70.
